SciQuus Oncology

Overview

SciQuus Oncology is a full-service contract research organization dedicated to oncology and hematology clinical trials. The company specializes in First-in-Human studies for new cancer therapies and offers a comprehensive range of services spanning preclinical development through Phase III clinical trials.

Core Capabilities

Preclinical Development: Expert-driven IND enabling studies and FDA consultations to guide innovation from discovery through regulatory submission.

Clinical Development: End-to-end trial management including protocol design, site selection, patient recruitment, and Phase I–III trial execution with rigorous quality standards.

Pharmacology & PK/PD: Specialized advice on pharmacology and pharmacokinetic/pharmacodynamic analyses to optimize drug development outcomes.

Oncology & Hematology Expertise: Proven solutions for complex oncologic and hematologic clinical research trials, with experience managing over 40 trials involving more than 850 patients across a broad spectrum of indications.

Differentiation

The company emphasizes senior leadership continuity, flexibility to adapt to changing trial priorities, and seamless integration with sponsor teams. SciQuus operates with a customized approach to each project, offering flexibility in engagement models—full program management or targeted functional support.